Kidney Cancer Diagnostics Market: By Type of Condition, By Type of Test, Uninalysis, Blood Chemistry Studies), By End user and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Kidney Cancer Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Condition (Renal Cell Carcinoma , Urothelial Carcinoma, Sarcoma, Wilms Tumor, Lymphoma), By Type of Test (Ultrasound, CT Scan, MRI, Radioisotope Scan, Tissue Biopsy, Intravenous Pyelogram (IVP), Uninalysis, Blood Chemistry Studies), By End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

The kidney cancer diagnostics market size was valued at US$ 3.2 billion in 2023, growing at a CAGR of 6.1% from 2024-2030. Kidney cancer begins when healthy cells in kidneys change and grow abnormally forming a mass called renal cortical tumor. A tumor can be malignant, indolent or benign. There are three main types of kidney cancers amongst renal cell cancer is the most common type of cancer in adults and wilms tumors are common in children. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.

In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing.

summary download arrow Download Free Sample

Kidney Cancer Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

Europe

Kidney Cancer Diagnostics Market Dynamics

Increase in the prevalence and incidence of kidney cancer and growing geriatric population propels the growth of the market globally. Furthermore increase in awareness regarding kidney cancers, drastic lifestyle changes, government initiatives drives the growth of the market globally. Moreover technological advancements, advanced healthcare services and increase in healthcare expenditure also propels the market growth of endometrial cancer diagnostics globally. However, rise in number of patient expirations, stringent regulatory framework, high cost associated with the tests and treatments, adverse effects and lack of awareness about innovative technologies may hinder the growth of the market globally.

Kidney Cancer Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3.2 billion

Market CAGR

6.1%

By Type of Condition

  • Renal Cell Carcinoma
  • Urothelial Carcinoma
  • Sarcoma
  • Wilms Tumor
  • Lymphoma

By Type of Test

  • Ultrasound
  • CT Scan
  • MRI
  • Radioisotope Scan
  • Tissue Biopsy
  • Intravenous Pyelogram (IVP)
  • Uninalysis
  • Blood Chemistry Studies

By End User

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The kidney cancer diagnostics market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The Kidney Cancer Diagnostics Market size was valued at US$ 3.2 billion in 2023, growing at a CAGR of 6.1% from 2024-2030.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Europe is the fastest-growing for the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

 

1.Executive Summary
2.Global Kidney Cancer Diagnostics Market Introduction 
2.1.Global Kidney Cancer Diagnostics Market  - Taxonomy
2.2.Global Kidney Cancer Diagnostics Market  - Definitions
2.2.1.Type of Condition
2.2.2.Type of Test
2.2.3.End User
2.2.4.Region
3.Global Kidney Cancer Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Kidney Cancer Diagnostics Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Kidney Cancer Diagnostics Market By Type of Condition, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Renal Cell Carcinoma
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Urothelial Carcinoma
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Sarcoma
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Wilms Tumor
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Lymphoma
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Kidney Cancer Diagnostics Market  By Type of Test, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Ultrasound
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. CT Scan
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. MRI
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Radioisotope Scan
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Tissue Biopsy
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Intravenous Pyelogram (IVP)
6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Uninalysis
6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Blood Chemistry Studies
6.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7.Global Kidney Cancer Diagnostics Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Diagnostic Centers
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Hospitals
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Kidney Cancer Diagnostics Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Kidney Cancer Diagnostics Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Type of Condition Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Renal Cell Carcinoma
9.1.2.Urothelial Carcinoma
9.1.3.Sarcoma
9.1.4.Wilms Tumor
9.1.5.Lymphoma
9.2.  Type of Test Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Ultrasound
9.2.2.CT Scan
9.2.3.MRI
9.2.4.Radioisotope Scan
9.2.5.Tissue Biopsy
9.2.6.Intravenous Pyelogram (IVP)
9.2.7.Uninalysis
9.2.8.Blood Chemistry Studies
9.3.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Diagnostic Centers
9.3.2.Hospitals
9.3.3.Ambulatory Surgical Centers
9.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Kidney Cancer Diagnostics Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Type of Condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Renal Cell Carcinoma
10.1.2.Urothelial Carcinoma
10.1.3.Sarcoma
10.1.4.Wilms Tumor
10.1.5.Lymphoma
10.2.  Type of Test Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Ultrasound
10.2.2.CT Scan
10.2.3.MRI
10.2.4.Radioisotope Scan
10.2.5.Tissue Biopsy
10.2.6.Intravenous Pyelogram (IVP)
10.2.7.Uninalysis
10.2.8.Blood Chemistry Studies
10.3.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Diagnostic Centers
10.3.2.Hospitals
10.3.3.Ambulatory Surgical Centers
10.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Kidney Cancer Diagnostics Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Type of Condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Renal Cell Carcinoma
11.1.2.Urothelial Carcinoma
11.1.3.Sarcoma
11.1.4.Wilms Tumor
11.1.5.Lymphoma
11.2.  Type of Test Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Ultrasound
11.2.2.CT Scan
11.2.3.MRI
11.2.4.Radioisotope Scan
11.2.5.Tissue Biopsy
11.2.6.Intravenous Pyelogram (IVP)
11.2.7.Uninalysis
11.2.8.Blood Chemistry Studies
11.3.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Diagnostic Centers
11.3.2.Hospitals
11.3.3.Ambulatory Surgical Centers
11.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Kidney Cancer Diagnostics Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. Type of Condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Renal Cell Carcinoma
12.1.2.Urothelial Carcinoma
12.1.3.Sarcoma
12.1.4.Wilms Tumor
12.1.5.Lymphoma
12.2.  Type of Test Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Ultrasound
12.2.2.CT Scan
12.2.3.MRI
12.2.4.Radioisotope Scan
12.2.5.Tissue Biopsy
12.2.6.Intravenous Pyelogram (IVP)
12.2.7.Uninalysis
12.2.8.Blood Chemistry Studies
12.3.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Diagnostic Centers
12.3.2.Hospitals
12.3.3.Ambulatory Surgical Centers
12.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Kidney Cancer Diagnostics Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
13.1. Type of Condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Renal Cell Carcinoma
13.1.2.Urothelial Carcinoma
13.1.3.Sarcoma
13.1.4.Wilms Tumor
13.1.5.Lymphoma
13.2.  Type of Test Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Ultrasound
13.2.2.CT Scan
13.2.3.MRI
13.2.4.Radioisotope Scan
13.2.5.Tissue Biopsy
13.2.6.Intravenous Pyelogram (IVP)
13.2.7.Uninalysis
13.2.8.Blood Chemistry Studies
13.3.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Diagnostic Centers
13.3.2.Hospitals
13.3.3.Ambulatory Surgical Centers
13.4.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Ariad Pharmaceuticals, Inc. (U.S)
14.2.2.Merck & Co., Inc. (U.S)
14.2.3.Abbott Laboratories (U.S)
14.2.4.Siemens Healthcare Inc. (Germany)
14.2.5.Hoffman-La Roche Ltd. (Switzerland)
14.2.6.Becton, Dickinson & Co. (U.S)
14.2.7.GlaxoSmithKline Plc., etc. (UK)
15. Research Methodology 
16. Appendix and Abbreviations

Key Market Players

  • Ariad Pharmaceuticals, Inc. (U.S)
  • Merck & Co., Inc. (U.S)
  • Abbott Laboratories (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Hoffman-La Roche Ltd. (Switzerland)
  • Becton, Dickinson & Co. (U.S)
  • GlaxoSmithKline Plc., etc. (UK)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market